Additionally, compared to the ACA-positive group, patients with SSA-positive pSS exhibited a significantly higher rate of hematological involvement, encompassing anemia, leukopenia, and neutropenia, than those in the ACA-positive group (P < 0.05). The gene discussed is CALR; the disease is anemia.